Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
LSL Pharma Group Inc ( (TSE:LSL) ) just unveiled an update.
LSL Pharma Group Inc. has announced significant changes to its board of directors, appointing Mr. Louis Laflamme as the new chairman and Mr. Noureddine Mokaddem as a new board member. These appointments are expected to enhance the company’s strategic governance and support its long-term growth ambitions, reflecting LSL Pharma’s commitment to solid governance and sustainable growth for the benefit of its shareholders and partners.
More about LSL Pharma Group Inc
LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company specializing in the development, manufacture, and marketing of high-quality sterile ophthalmic pharmaceuticals, as well as natural pharmaceutical, cosmetic, and health products in solid, semi-solid, and liquid forms. The company includes subsidiaries such as Steri-Med Pharma Inc., Laboratoire LSL Inc., Virage Santé Inc., and Dermolab Pharma Ltée.
Average Trading Volume: 44,718
Technical Sentiment Signal: Strong Sell
Find detailed analytics on LSL stock on TipRanks’ Stock Analysis page.